From The Editor | March 18, 2013

Former Acorda Chief Medical Officer Discusses Benefits And Pitfalls Of Outsourcing

By Ed Miseta, Chief Editor, Clinical Leader

Ed Miseta

Dr. Thomas C. Wessel, M.D., Ph.D., is the former chief medical officer for Acorda Therapeutics. In his role, Wessel reported to CEO and founder, Ron Cohen, M.D., and was responsible for the company’s clinical development and operations, regulatory affairs, biostatistics, data management and drug safety functions. Previously, he served as the senior VP of clinical research of Sepracor Inc., where he led the central nervous system (CNS) and respiratory medicine development teams, including clinical research and operations, clinical pharmacology, drug safety and medical writing and also served as its VP of CNS Development.

access the From The Editor!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)